The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Effectiveness of population‐based service screening with mammography for women ages 40 to 49 years: Evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort
Open accessAbstract
BACKGROUND: The effectiveness of mammography screening for women ages 40 to 49 years still is questioned, and few studies of the effectiveness of service screening for this age group have been conducted. METHODS: Breast cancer mortality was compared between women who were invited to service screening at ages 40 to 49 years (study group) and women in the same age group who were not invited during 1986 to 2005 (control group). Together, these women comprise the Mammography Screening of Young Women (SCRY) cohort, which includes all Swedish counties. A prescreening period was defined to facilitate a comparison of mortality in the absence of screening. The outcome measure was refined mortality, ie, breast cancer death for women who were diagnosed during follow‐up at ages 40 to 49 years. Relative risks (RRs) with 95% confidence intervals (CIs) were estimated. RESULTS: There was no significant difference in breast cancer mortality during the prescreening period. During the study period, there were 803 breast cancer deaths in the study group (7.3 million person‐years) and 1238 breast cancer deaths in the control group (8.8 million person‐years). The average follow‐up was 16 years. The estimated RR for women who were invited to screening was 0.74 (95% CI, 0.66‐0.83), and the RR for women who attended screening was 0.71 (95% CI, 0.62‐0.80). CONCLUSIONS: In this comprehensive study, mammography screening for women ages 40 to 49 years was efficient for reducing breast cancer mortality. Cancer 2011. © 2010 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY
Tabár, L., Gad, A., Holmberg, L. H., Ljungquist, U., Fagerberg, C. J. G., Baldetorp, L., Gröntoft, O., Lundström, B., Månson, J. C., Eklund, G., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92204-4 · Cited by 1,781
Self-citationScreening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Perry, N., Broeders, M., de Wolf, C., Törnberg, S., Holland, R., & von Karsa, L. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm481 · Cited by 1,020
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F., Ljungberg, O., Ranstam, J., & Sigfússon, B. (1988) · BMJ · doi:10.1136/bmj.297.6654.943 · Cited by 916
Moss, S. M., Cuckle, H., Evans, A., Johns, L., Waller, M., & Bobrow, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69834-6 · Cited by 503
Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer
Shapiro, S. (1971) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1971.03180240027005 · Cited by 499
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00005 · Cited by 394
ADJUSTING FOR NON-COMPLIANCE AND CONTAMINATION IN RANDOMIZED CLINICAL TRIALS
CUZICK, J., EDWARDS, R., & SEGNAN, N. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970515)16:9<1017::aid-sim508>3.0.co;2-v · Cited by 309
Randomized study of mammography screening — preliminary report on mortality in the stockholm trial
Frisell, J., Eklund, G., Hellström, L., Lidbrink, E., Rutqvist, L. E., & Somell, A. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01975443 · Cited by 258
Andersson, I., & Janzon, L. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.63 · Cited by 250
Bjurstam, N., Björneld, L., Duffy, S. W., Smith, T. C., Cahlin, E., Eriksson, O., Hafström, L., Lingaas, H., Mattsson, J., Persson, S., et al. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971201)80:11<2091::aid-cncr8>3.0.co;2-# · Cited by 207
Self-citationMarkov Models of Breast Tumor Progression: Some Age-Specific Results
Duffy, S. W., Day, N., Tabár, L. K., Chen, H.-H., & Smith, T. C. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.93 · Cited by 113
Self-citationThe Gothenburg Breast Screening Trial
Bjurstam, N., Björneld, L., Duffy, S. W., Smith, T. C., Cahlin, E., Eriksson, O., Hafström, L., Lingaas, H., Mattsson, J., Persson, S., et al. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199803000-00016 · Cited by 81
Self-citationJonsson, S. (2000) · Acta Oncologica · doi:10.1080/028418600750013302 · Cited by 49
Cited by
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2015.13183 · Cited by 637
Nelson, H. D., Fu, R., Cantor, A., Pappas, M., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0969 · Cited by 611
Metadata
- Authors
- Hellquist, B. N., Duffy, S. W., Abdsaleh, S., Björneld, L., Bordás, P., Tabár, L., Viták, B., Zackrisson, S., Nyström, L., & Jonsson, H.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2010-09-29
- Volume
- 117
- Issue
- 4
- Pages
- 714-722
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2157129699
- Cited by
- 254
- References
- 14
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.